Pharmaceuticals

January 2021

Pharma UK: The Transdermal Technology – Compact Case

By Julian Birkinshaw

Pharma UK was the UK subsidiary of Pharma, a major international pharmaceuticals company with expertise in oncology, hormone replacement drugs and fertility. Pharma UK was responsible for selling drugs in the local marketplace. However, it also had 50 people in R&D, doing local development work ...

October 2020

Takeda: The governance of strategic transformation (B) (Japanese)

By Harry Korine, Kazuhiro Asakawa

The case series describes strategic transformation at Takeda, the largest Japanese pharmaceutical company, with a special focus on the R&D function. Since 2015, the 237-year-old industry doyen has narrowed its strategic focus from six to three therapeutic areas, reorganised its global R&D fo...

October 2020

Takeda: The Governance of Strategic Transformation (A) (Japanese)

By Harry Korine, Kazuhiro Asakawa

The case series describes strategic transformation at Takeda, the largest Japanese pharmaceutical company, with a special focus on the R&D function. Since 2015, the 237-year-old industry doyen has narrowed its strategic focus from six to three therapeutic areas, reorganised its global R&D fo...

September 2018

David Pyott: The Battle for Allergan (B)

By Randall Peterson, Lisa Duke

This case series charts the evolution of the hostile battle for Allergan and its ultimate sale to a white knight, Actavis. David Pyott had been the CEO of Allergan since January 1998; only the third CEO in the company’s 60-year-plus history. Allergan was primarily known for Botox, the aesthetic an...

November 2018

Takeda: The governance of strategic transformation (B)

By Harry Korine, Kazuhiro Asakawa

The case series describes strategic transformation at Takeda, the largest Japanese pharmaceutical company, with a special focus on the R&D function. Since 2015, the 237-year-old industry doyen has narrowed its strategic focus from six to three therapeutic areas, reorganised its global R&D fo...

November 2018

Takeda: The governance of strategic transformation (A)

By Harry Korine, Kazuhiro Asakawa

The case series describes strategic transformation at Takeda, the largest Japanese pharmaceutical company, with a special focus on the R&D function. Since 2015, the 237-year-old industry doyen has narrowed its strategic focus from six to three therapeutic areas, reorganised its global R&D fo...